Abstract:Background: Post-acute sequalae of COVID-19 defines a wide range of ongoing symptoms and conditions long after SARS-CoV-2 infection including respiratory diseases. The histopathological changes in the lung and underlying mechanism remain elusive. Methods: We investigated lung histopathological and transcriptional changes in SARS-CoV-2-infected male hamsters at 7, 14, 42, 84 and 120dpi, and compared with A (H1N1)pdm09 infection. Findings: We demonstrated viral residue, inflammatory and fibrotic changes in lung after SARS-CoV-2 but not H1N1 infection. The most prominent histopathological lesion was multifocal alveolar-bronchiolization observed in every SARS-CoV-2 infected hamster (31/31), from 42dpi to 120dpi. Proliferating (Ki67+) CK14+ basal cells accumulated in alveoli adjacent to bronchioles at 7dpi, where they proliferated and differentiated into SCGB1A+ club cell or Tubulin+ ciliated cells forming alveolar-bronchiolization foci. Molecularly, Notch pathway significantly upregulated with intensive Notch3 and Hes1 protein expression in alveolar-bronchiolization foci at 42 and 120dpi, suggesting Notch signaling involving the persistence of alveolar-bronchiolization. This is further demonstrated by spatial transcriptomic analysis. Intriguingly, significant upregulation of some cell-growth promoting pathways and genes such as Tubb4b, Stxbp4, Grb14 and Mlf1 were spatially overlapping with bronchiolization lesion. Interpretation: Incomplete resolution of SARS-CoV-2 infection in lung with viral residue, chronic inflammatory and fibrotic damage and alveolar-bronchiolization impaired respiratory function. Aberrant activation of CK14+ basal cells during tissue regeneration led to persistent alveolar-bronchiolization due to sustained Notch signaling. This study advances our understanding of respiratory PASC, sheds light on disease management and highlights the necessity for monitoring disease progression in people with respiratory PASC. Funding: Funding is listed in the Acknowledgements section.

Distal Airway Stem Cells Yield Alveoli In Vitro and during Lung Regeneration following H1N1 Influenza Infection

P63(+)krt5(+) Distal Airway Stem Cells Are Essential for Lung Regeneration.

Longitudinal single cell transcriptomics reveals Krt8+ alveolar epithelial progenitors in lung regeneration

Alveolar regeneration following viral infection is independent of tuft cells

Alternative Progenitor Lineages Regenerate the Adult Lung Depleted of Alveolar Epithelial Type 2 Cells

Stable Long-Term Culture of Human Distal Airway Stem Cells for Transplantation

Alveolar regeneration by airway secretory-cell-derived p63+ progenitors

Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis

Airway secretory cell-derived p63+ progenitors contribute to alveolar regeneration after sterile lung injury

Crucial role played by CK8+ cells in mediating alveolar injury remodeling for patients with COVID-19

Intrapulmonary distal airway stem cell transplantation repairs lung injury in chronic obstructive pulmonary disease

Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction

Genetically Engineered Distal Airway Stem Cell Transplantation Protects Mice from Pulmonary Infection

Pulmonary alveolar regrowth in an adult COVID-19 patient

Contribution of Trp63CreERT2-labeled Cells to Alveolar Regeneration is Independent of Tuft Cells

Viral infection induces inflammatory signals that coordinate YAP regulation of dysplastic cells in lung alveoli

Human mesenchymal stromal cells reduce influenza A H5N1-associated acute lung injury in vitro and in vivo.

Chronic lung inflammation and CK14+ basal cell proliferation induce persistent alveolar-bronchiolization in SARS-CoV-2-infected hamsters

Human distal airways contain a multipotent secretory cell that can regenerate alveoli

Epithelial plasticity and innate immune activation promote lung tissue remodeling following respiratory viral infection

Single-cell Analysis Reveals the Function of Lung Progenitor Cells in COVID-19 Patients